Using the DNA-binding domain of androgen receptor (AR) as a bait in a yeast two-hybrid screening, we have identified a small nuclear RING finger protein, termed SNURF, that interacts with AR in a hormonedependent fashion in both yeast and mammalian cells. Physical interaction between AR and SNURF was demonstrated by coimmunoprecipitation from cell extracts and by protein-protein affinity chromatography. Rat SNURF is a highly hydrophilic protein consisting of 194 amino acid residues and comprising a consensus C 3 HC 4 zinc finger (RING) structure in the C-terminal region and a bipartite nuclear localization signal near the N terminus. Immunohistochemical experiments indicated that SNURF is a nuclear protein. SNURF mRNA is expressed in a variety of human and rat tissues. Overexpression of SNURF in cultured mammalian cells enhanced not only androgen, glucocorticoid, and progesterone receptor-dependent transactivation but also basal transcription from steroid-regulated promoters. Mutation of two of the potential Zn 2؉ coordinating cysteines to serines in the RING finger completely abolished the ability of SNURF to enhance basal transcription, whereas its ability to activate steroid receptor-dependent transcription was maintained, suggesting that there are separate domains in SNURF that mediate interactions with different regulatory factors. SNURF is capable of interacting in vitro with the TATA-binding protein, and the RING finger domain is needed for this interaction. Collectively, we have identified and characterized a ubiquitously expressed RING finger protein, SNURF, that may function as a bridging factor and regulate steroid receptor-dependent transcription by a mechanism different from those of previously identified coactivator or integrator proteins.Androgen receptor (AR) that mediates the biological actions of physiological androgens is a member of the superfamily of ligand-inducible transcription factors (59). Like other nuclear receptors, AR contains three major structural and interchangeable domains: the N-terminal transactivation domain, the central DNA-binding domain (DBD) that associates with specific androgen response elements (AREs) in target genes, and the C-terminal ligand binding domain (LBD) that binds physiological and synthetic androgens. Upon ligand binding, AR acquires a new conformational state (39), which enables the receptor to interact with AREs and converts the protein to a transcriptional activator. Molecular analyses have shown that the N-terminal half of AR, similar to that of other steroid receptors, contains sequences responsible for the activation function AF-1 (11,34,37,47,54,59,65). In addition to AF-1, another activation function (AF-2) has been identified in the LBDs of various nuclear receptors, including AR (11, 51). Besides encompassing nuclear localization signal (NLS) (38,65,75), the functional role of the hinge region residing between the DBDs and LBDs of steroid receptors has remained elusive.Nuclear receptors have been shown to contact the basal transcription machinery,...